Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.13816981 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.13816981 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.88358725 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.88358725 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.62410771 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.34709123 |
7 | indole-containing compound catabolic process (GO:0042436) | 5.19374109 |
8 | indolalkylamine catabolic process (GO:0046218) | 5.19374109 |
9 | tryptophan catabolic process (GO:0006569) | 5.19374109 |
10 | tryptophan metabolic process (GO:0006568) | 4.97732239 |
11 | kynurenine metabolic process (GO:0070189) | 4.96024551 |
12 | urea metabolic process (GO:0019627) | 4.89396776 |
13 | urea cycle (GO:0000050) | 4.89396776 |
14 | bile acid biosynthetic process (GO:0006699) | 4.88863387 |
15 | protein carboxylation (GO:0018214) | 4.85916175 |
16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.85916175 |
17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82308732 |
18 | complement activation, alternative pathway (GO:0006957) | 4.82244782 |
19 | regulation of protein activation cascade (GO:2000257) | 4.79179855 |
20 | alpha-linolenic acid metabolic process (GO:0036109) | 4.78789276 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77545336 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.58260026 |
23 | glyoxylate metabolic process (GO:0046487) | 4.58056594 |
24 | regulation of complement activation (GO:0030449) | 4.54775384 |
25 | nitrogen cycle metabolic process (GO:0071941) | 4.48634038 |
26 | negative regulation of fibrinolysis (GO:0051918) | 4.47650321 |
27 | sulfur amino acid catabolic process (GO:0000098) | 4.47514550 |
28 | cysteine metabolic process (GO:0006534) | 4.45557685 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 4.33533972 |
30 | regulation of fibrinolysis (GO:0051917) | 4.25538793 |
31 | phospholipid efflux (GO:0033700) | 4.25139685 |
32 | homocysteine metabolic process (GO:0050667) | 4.22489035 |
33 | aromatic amino acid family metabolic process (GO:0009072) | 4.19952727 |
34 | bile acid metabolic process (GO:0008206) | 4.18663041 |
35 | amino-acid betaine metabolic process (GO:0006577) | 4.16036064 |
36 | regulation of cholesterol esterification (GO:0010872) | 4.14876996 |
37 | reverse cholesterol transport (GO:0043691) | 4.12159676 |
38 | plasma lipoprotein particle clearance (GO:0034381) | 4.05507536 |
39 | tyrosine metabolic process (GO:0006570) | 4.03801856 |
40 | protein-lipid complex remodeling (GO:0034368) | 4.03418900 |
41 | macromolecular complex remodeling (GO:0034367) | 4.03418900 |
42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.03418900 |
43 | serine family amino acid catabolic process (GO:0009071) | 4.02957634 |
44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.95537247 |
45 | cholesterol efflux (GO:0033344) | 3.85552152 |
46 | bile acid and bile salt transport (GO:0015721) | 3.82266282 |
47 | negative regulation of cell killing (GO:0031342) | 3.78371966 |
48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78371966 |
49 | triglyceride homeostasis (GO:0070328) | 3.76612203 |
50 | acylglycerol homeostasis (GO:0055090) | 3.76612203 |
51 | lysine metabolic process (GO:0006553) | 3.76609481 |
52 | lysine catabolic process (GO:0006554) | 3.76609481 |
53 | indolalkylamine metabolic process (GO:0006586) | 3.76509596 |
54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.73346472 |
55 | negative regulation of sterol transport (GO:0032372) | 3.71655115 |
56 | negative regulation of cholesterol transport (GO:0032375) | 3.71655115 |
57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70895349 |
58 | neutrophil activation involved in immune response (GO:0002283) | 3.68659018 |
59 | alpha-amino acid catabolic process (GO:1901606) | 3.66803097 |
60 | coenzyme catabolic process (GO:0009109) | 3.63398116 |
61 | cofactor catabolic process (GO:0051187) | 3.58387137 |
62 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.58333587 |
63 | phospholipid homeostasis (GO:0055091) | 3.53034025 |
64 | cellular glucuronidation (GO:0052695) | 3.52850152 |
65 | fibrinolysis (GO:0042730) | 3.50997405 |
66 | amine catabolic process (GO:0009310) | 3.50421960 |
67 | cellular biogenic amine catabolic process (GO:0042402) | 3.50421960 |
68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49237320 |
69 | benzene-containing compound metabolic process (GO:0042537) | 3.49162035 |
70 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48678080 |
71 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48678080 |
72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48313549 |
73 | plasma lipoprotein particle assembly (GO:0034377) | 3.47593550 |
74 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.47315773 |
75 | aldehyde catabolic process (GO:0046185) | 3.43915027 |
76 | low-density lipoprotein particle remodeling (GO:0034374) | 3.42066674 |
77 | complement activation, classical pathway (GO:0006958) | 3.41316795 |
78 | complement activation (GO:0006956) | 3.38963579 |
79 | positive regulation of lipid catabolic process (GO:0050996) | 3.38354713 |
80 | cellular amino acid catabolic process (GO:0009063) | 3.37504989 |
81 | acute-phase response (GO:0006953) | 3.36255581 |
82 | arginine metabolic process (GO:0006525) | 3.35039234 |
83 | opsonization (GO:0008228) | 3.34158751 |
84 | NAD biosynthetic process (GO:0009435) | 3.32118882 |
85 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.32073381 |
86 | drug catabolic process (GO:0042737) | 3.29633680 |
87 | protein activation cascade (GO:0072376) | 3.29454506 |
88 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.28377544 |
89 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.28377544 |
90 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27191372 |
91 | cellular ketone body metabolic process (GO:0046950) | 3.25524733 |
92 | positive regulation of granulocyte differentiation (GO:0030854) | 3.23925676 |
93 | cholesterol homeostasis (GO:0042632) | 3.23815720 |
94 | glucuronate metabolic process (GO:0019585) | 3.23210693 |
95 | uronic acid metabolic process (GO:0006063) | 3.23210693 |
96 | urate metabolic process (GO:0046415) | 3.22116768 |
97 | protein-lipid complex assembly (GO:0065005) | 3.22036125 |
98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.21387875 |
99 | sterol homeostasis (GO:0055092) | 3.20102879 |
100 | plasma lipoprotein particle organization (GO:0071827) | 3.19644133 |
101 | ethanol oxidation (GO:0006069) | 3.19570895 |
102 | negative T cell selection (GO:0043383) | 3.19256979 |
103 | tolerance induction (GO:0002507) | 3.19251136 |
104 | cellular modified amino acid catabolic process (GO:0042219) | 3.18704736 |
105 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.17882566 |
106 | carnitine metabolic process (GO:0009437) | 3.16228507 |
107 | serine family amino acid metabolic process (GO:0009069) | 3.15693505 |
108 | negative thymic T cell selection (GO:0045060) | 3.15097278 |
109 | regulation of cholesterol homeostasis (GO:2000188) | 3.13107126 |
110 | glycine metabolic process (GO:0006544) | 3.12866205 |
111 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.12775502 |
112 | lipoprotein metabolic process (GO:0042157) | 3.12308202 |
113 | organic acid catabolic process (GO:0016054) | 3.10837398 |
114 | carboxylic acid catabolic process (GO:0046395) | 3.10837398 |
115 | glutamate metabolic process (GO:0006536) | 3.10691786 |
116 | cellular extravasation (GO:0045123) | 3.08373962 |
117 | regulation of regulatory T cell differentiation (GO:0045589) | 3.07554114 |
118 | response to interleukin-15 (GO:0070672) | 3.06838600 |
119 | valine metabolic process (GO:0006573) | 3.06761838 |
120 | protein-lipid complex subunit organization (GO:0071825) | 3.06607526 |
121 | regulation of tolerance induction (GO:0002643) | 2.98217526 |
122 | detection of other organism (GO:0098543) | 2.97169711 |
123 | response to peptidoglycan (GO:0032494) | 2.88574798 |
124 | definitive hemopoiesis (GO:0060216) | 2.82941858 |
125 | detection of bacterium (GO:0016045) | 2.81249848 |
126 | positive regulation of B cell differentiation (GO:0045579) | 2.81172984 |
127 | positive regulation of tolerance induction (GO:0002645) | 2.79060561 |
128 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77959429 |
129 | immunoglobulin mediated immune response (GO:0016064) | 2.76054513 |
130 | regulation of T cell tolerance induction (GO:0002664) | 2.75994856 |
131 | T cell migration (GO:0072678) | 2.73477795 |
132 | neutrophil activation (GO:0042119) | 2.72654013 |
133 | regulation of mast cell degranulation (GO:0043304) | 2.70458616 |
134 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69109887 |
135 | positive thymic T cell selection (GO:0045059) | 2.68047962 |
136 | granulocyte activation (GO:0036230) | 2.62775433 |
137 | positive regulation of mast cell activation (GO:0033005) | 2.62300824 |
138 | detection of external biotic stimulus (GO:0098581) | 2.60161427 |
139 | positive regulation by symbiont of host defense response (GO:0052509) | 2.58301726 |
140 | modulation by symbiont of host defense response (GO:0052031) | 2.58301726 |
141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.58301726 |
142 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.58301726 |
143 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.58301726 |
144 | modulation by symbiont of host immune response (GO:0052553) | 2.58301726 |
145 | negative regulation of interleukin-12 production (GO:0032695) | 2.58241891 |
146 | cellular response to ethanol (GO:0071361) | 2.56978752 |
147 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56641602 |
148 | positive T cell selection (GO:0043368) | 2.54266633 |
149 | detection of molecule of bacterial origin (GO:0032490) | 2.52991772 |
150 | hypotonic response (GO:0006971) | 2.52288314 |
151 | regulation of hypersensitivity (GO:0002883) | 2.51348343 |
152 | regulation of granulocyte differentiation (GO:0030852) | 2.51055790 |
153 | myeloid cell activation involved in immune response (GO:0002275) | 2.50894818 |
154 | leukocyte aggregation (GO:0070486) | 2.50866241 |
155 | B cell receptor signaling pathway (GO:0050853) | 2.50793533 |
156 | T cell selection (GO:0045058) | 2.50206130 |
157 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49603068 |
158 | response to type I interferon (GO:0034340) | 2.47251364 |
159 | cellular response to interleukin-15 (GO:0071350) | 2.47018421 |
160 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.46663803 |
161 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.45303723 |
162 | regulation of macrophage chemotaxis (GO:0010758) | 2.45162375 |
163 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.44754449 |
164 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.44754449 |
165 | germinal center formation (GO:0002467) | 2.44450327 |
166 | cellular response to type I interferon (GO:0071357) | 2.44397315 |
167 | type I interferon signaling pathway (GO:0060337) | 2.44397315 |
168 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.42879075 |
169 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.42313386 |
170 | regulation of germinal center formation (GO:0002634) | 2.42004593 |
171 | regulation of mast cell activation (GO:0033003) | 2.41942032 |
172 | thymic T cell selection (GO:0045061) | 2.41345315 |
173 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.40938549 |
174 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.40542246 |
175 | response to muramyl dipeptide (GO:0032495) | 2.40293387 |
176 | pinocytosis (GO:0006907) | 2.39222920 |
177 | negative regulation of humoral immune response (GO:0002921) | 2.39074967 |
178 | positive regulation of macrophage differentiation (GO:0045651) | 2.37968947 |
179 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37529873 |
180 | regulation of leukocyte degranulation (GO:0043300) | 2.37384277 |
181 | macrophage activation involved in immune response (GO:0002281) | 2.37143292 |
182 | mast cell activation (GO:0045576) | 2.35929909 |
183 | regulation of B cell differentiation (GO:0045577) | 2.35502148 |
184 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.34425209 |
185 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.33936288 |
186 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.32420012 |
187 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.31040891 |
188 | leukocyte degranulation (GO:0043299) | 2.30948139 |
189 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.30210033 |
190 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.29895432 |
191 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.28855445 |
192 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.28474270 |
193 | positive regulation of mast cell degranulation (GO:0043306) | 2.28474270 |
194 | negative regulation of granulocyte differentiation (GO:0030853) | 2.26492332 |
195 | negative regulation of complement activation (GO:0045916) | 2.26000649 |
196 | hepatocyte apoptotic process (GO:0097284) | 2.25813119 |
197 | negative regulation of innate immune response (GO:0045824) | 2.25625022 |
198 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.25376704 |
199 | negative regulation of adaptive immune response (GO:0002820) | 2.25351025 |
200 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.25267356 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.10265527 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52343532 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.66881273 |
4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.63676829 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.14734975 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.16563592 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.08511877 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.06398550 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.91183759 |
10 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.84289267 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.11019655 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.94643397 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.73133466 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.42029735 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38894234 |
16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19103045 |
17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16386882 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11902805 |
19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08894314 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.07591954 |
21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.02791840 |
22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97126599 |
23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95904053 |
24 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90902513 |
25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90328678 |
26 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77297771 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74278284 |
28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74191537 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 1.70182955 |
30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65330515 |
31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64175257 |
32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59538264 |
33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58288782 |
34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57885483 |
35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54014287 |
36 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51448947 |
37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.51126035 |
38 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50456055 |
39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50382612 |
40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48065684 |
41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47618920 |
42 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47233618 |
43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44725734 |
44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44459610 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43752079 |
46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39938759 |
47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36434101 |
48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30933654 |
49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29665964 |
50 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29294481 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28744849 |
52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24646618 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23958238 |
54 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23660621 |
55 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20912980 |
56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19359197 |
57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18310852 |
58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17394642 |
59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12161963 |
60 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11065798 |
61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09319981 |
62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09021199 |
63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08296648 |
64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06827598 |
65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05262241 |
66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02939692 |
67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02939692 |
68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02216410 |
69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00748056 |
70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00577323 |
71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97779116 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96197447 |
73 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93862173 |
74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92473783 |
75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92211759 |
76 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91435513 |
77 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.91372387 |
78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89453391 |
79 | MAF_26560356_Chip-Seq_TH2_Human | 0.88302192 |
80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87509574 |
81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87370887 |
82 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86633271 |
83 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85997818 |
84 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85762378 |
85 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85762378 |
86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84976720 |
87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84420868 |
88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84325046 |
89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82191991 |
90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81966128 |
91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81856678 |
92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80885136 |
93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80418217 |
94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79719911 |
95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.78499437 |
96 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78188372 |
97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77841513 |
98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77825886 |
99 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.77692323 |
100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76240390 |
101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75728768 |
102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75601485 |
103 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.75374094 |
104 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.73750033 |
105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73627788 |
106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73133272 |
107 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72829520 |
108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72343790 |
109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72134460 |
110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.72042371 |
111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71836581 |
112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.68929158 |
113 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68454125 |
114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.67947388 |
115 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64077135 |
116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63957997 |
117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.63858966 |
118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63415697 |
119 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.62765685 |
120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62248080 |
121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62189464 |
122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62168676 |
123 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.62115110 |
124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.61694429 |
125 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.61682152 |
126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61584554 |
127 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.61508959 |
128 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60978317 |
129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60846293 |
130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60228087 |
131 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.59961694 |
132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59331426 |
133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59130190 |
134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58801114 |
135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.57861841 |
136 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57490607 |
137 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57248250 |
138 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57029736 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.56068123 |
2 | MP0005360_urolithiasis | 6.07901369 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.01711546 |
4 | MP0005365_abnormal_bile_salt | 4.92944703 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.12095924 |
6 | MP0009840_abnormal_foam_cell | 3.47202478 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.22691141 |
8 | MP0003252_abnormal_bile_duct | 3.13376055 |
9 | MP0010329_abnormal_lipoprotein_level | 3.00542849 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.67630317 |
11 | MP0003195_calcinosis | 2.57107709 |
12 | MP0005083_abnormal_biliary_tract | 2.49575352 |
13 | MP0003763_abnormal_thymus_physiology | 2.46316659 |
14 | MP0005332_abnormal_amino_acid | 2.45170512 |
15 | MP0000465_gastrointestinal_hemorrhage | 2.31362414 |
16 | MP0001666_abnormal_nutrient_absorption | 2.07266868 |
17 | MP0000609_abnormal_liver_physiology | 2.05280308 |
18 | MP0004019_abnormal_vitamin_homeostasis | 1.97030129 |
19 | MP0002420_abnormal_adaptive_immunity | 1.91177873 |
20 | MP0002118_abnormal_lipid_homeostasis | 1.89228138 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.83658220 |
22 | MP0003724_increased_susceptibility_to | 1.83616594 |
23 | MP0005058_abnormal_lysosome_morphology | 1.83174474 |
24 | MP0005319_abnormal_enzyme/_coenzyme | 1.79739505 |
25 | MP0003828_pulmonary_edema | 1.76124112 |
26 | MP0002405_respiratory_system_inflammati | 1.73946459 |
27 | MP0001835_abnormal_antigen_presentation | 1.61423969 |
28 | MP0009764_decreased_sensitivity_to | 1.60520826 |
29 | MP0001764_abnormal_homeostasis | 1.57287564 |
30 | MP0003436_decreased_susceptibility_to | 1.56670529 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 1.53482161 |
32 | MP0002398_abnormal_bone_marrow | 1.53336743 |
33 | MP0003868_abnormal_feces_composition | 1.51898516 |
34 | MP0006082_CNS_inflammation | 1.51759089 |
35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51249240 |
36 | MP0009697_abnormal_copulation | 1.48687500 |
37 | MP0000716_abnormal_immune_system | 1.48016658 |
38 | MP0009785_altered_susceptibility_to | 1.47546379 |
39 | MP0002132_abnormal_respiratory_system | 1.46804870 |
40 | MP0008469_abnormal_protein_level | 1.45152027 |
41 | MP0000604_amyloidosis | 1.43351394 |
42 | MP0008004_abnormal_stomach_pH | 1.42844332 |
43 | MP0003866_abnormal_defecation | 1.42826261 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.40764829 |
45 | MP0001851_eye_inflammation | 1.38987953 |
46 | MP0005397_hematopoietic_system_phenotyp | 1.37102205 |
47 | MP0001545_abnormal_hematopoietic_system | 1.37102205 |
48 | MP0009643_abnormal_urine_homeostasis | 1.36609402 |
49 | MP0003186_abnormal_redox_activity | 1.35972035 |
50 | MP0000689_abnormal_spleen_morphology | 1.34291264 |
51 | MP0001873_stomach_inflammation | 1.32267315 |
52 | MP0000858_altered_metastatic_potential | 1.30242948 |
53 | MP0005409_darkened_coat_color | 1.28260474 |
54 | MP0002722_abnormal_immune_system | 1.25691698 |
55 | MP0003011_delayed_dark_adaptation | 1.25153406 |
56 | MP0005464_abnormal_platelet_physiology | 1.24877796 |
57 | MP0002419_abnormal_innate_immunity | 1.23243517 |
58 | MP0009763_increased_sensitivity_to | 1.22262798 |
59 | MP0000598_abnormal_liver_morphology | 1.19273594 |
60 | MP0002429_abnormal_blood_cell | 1.18535191 |
61 | MP0002396_abnormal_hematopoietic_system | 1.15027626 |
62 | MP0004381_abnormal_hair_follicle | 1.13895445 |
63 | MP0002254_reproductive_system_inflammat | 1.11809606 |
64 | MP0004883_abnormal_blood_vessel | 1.11484822 |
65 | MP0002933_joint_inflammation | 1.10389118 |
66 | MP0005451_abnormal_body_composition | 1.08003706 |
67 | MP0005025_abnormal_response_to | 1.07871920 |
68 | MP0000703_abnormal_thymus_morphology | 1.04803344 |
69 | MP0003045_fibrosis | 1.04287373 |
70 | MP0004130_abnormal_muscle_cell | 1.04228258 |
71 | MP0002009_preneoplasia | 1.01525218 |
72 | MP0005670_abnormal_white_adipose | 1.01511617 |
73 | MP0009278_abnormal_bone_marrow | 1.01120894 |
74 | MP0002006_tumorigenesis | 0.99336017 |
75 | MP0005636_abnormal_mineral_homeostasis | 0.98730364 |
76 | MP0001845_abnormal_inflammatory_respons | 0.97669419 |
77 | MP0003690_abnormal_glial_cell | 0.96791743 |
78 | MP0004808_abnormal_hematopoietic_stem | 0.96641874 |
79 | MP0005647_abnormal_sex_gland | 0.96040218 |
80 | MP0005387_immune_system_phenotype | 0.94268427 |
81 | MP0001790_abnormal_immune_system | 0.94268427 |
82 | MP0001533_abnormal_skeleton_physiology | 0.93676184 |
83 | MP0004510_myositis | 0.92812665 |
84 | MP0009642_abnormal_blood_homeostasis | 0.92647382 |
85 | MP0010368_abnormal_lymphatic_system | 0.92113810 |
86 | MP0000685_abnormal_immune_system | 0.91787583 |
87 | MP0001756_abnormal_urination | 0.90994234 |
88 | MP0005165_increased_susceptibility_to | 0.89918841 |
89 | MP0003300_gastrointestinal_ulcer | 0.89015713 |
90 | MP0005310_abnormal_salivary_gland | 0.86767221 |
91 | MP0004947_skin_inflammation | 0.85527506 |
92 | MP0005666_abnormal_adipose_tissue | 0.85405848 |
93 | MP0003453_abnormal_keratinocyte_physiol | 0.84797442 |
94 | MP0003172_abnormal_lysosome_physiology | 0.84233430 |
95 | MP0003448_altered_tumor_morphology | 0.83994251 |
96 | MP0005408_hypopigmentation | 0.83896751 |
97 | MP0008438_abnormal_cutaneous_collagen | 0.83561887 |
98 | MP0005000_abnormal_immune_tolerance | 0.83113879 |
99 | MP0002876_abnormal_thyroid_physiology | 0.81850910 |
100 | MP0003705_abnormal_hypodermis_morpholog | 0.81287477 |
101 | MP0001800_abnormal_humoral_immune | 0.81219036 |
102 | MP0004484_altered_response_of | 0.80589305 |
103 | MP0002148_abnormal_hypersensitivity_rea | 0.80336124 |
104 | MP0002723_abnormal_immune_serum | 0.78073828 |
105 | MP0009765_abnormal_xenobiotic_induced | 0.77758663 |
106 | MP0001853_heart_inflammation | 0.77548478 |
107 | MP0005166_decreased_susceptibility_to | 0.77262944 |
108 | MP0002136_abnormal_kidney_physiology | 0.76987338 |
109 | MP0003950_abnormal_plasma_membrane | 0.75736869 |
110 | MP0002166_altered_tumor_susceptibility | 0.75605425 |
111 | MP0005334_abnormal_fat_pad | 0.75601172 |
112 | MP0008260_abnormal_autophagy | 0.75541422 |
113 | MP0003075_altered_response_to | 0.73625553 |
114 | MP0002971_abnormal_brown_adipose | 0.72104041 |
115 | MP0005671_abnormal_response_to | 0.71963356 |
116 | MP0001661_extended_life_span | 0.71896932 |
117 | MP0002452_abnormal_antigen_presenting | 0.71819287 |
118 | MP0003303_peritoneal_inflammation | 0.71566952 |
119 | MP0002078_abnormal_glucose_homeostasis | 0.70805188 |
120 | MP0006036_abnormal_mitochondrial_physio | 0.69738495 |
121 | MP0005376_homeostasis/metabolism_phenot | 0.68627649 |
122 | MP0005410_abnormal_fertilization | 0.68616860 |
123 | MP0001542_abnormal_bone_strength | 0.67974963 |
124 | MP0000249_abnormal_blood_vessel | 0.66446735 |
125 | MP0005535_abnormal_body_temperature | 0.66181843 |
126 | MP0005164_abnormal_response_to | 0.63660625 |
127 | MP0004782_abnormal_surfactant_physiolog | 0.62235396 |
128 | MP0010155_abnormal_intestine_physiology | 0.58797106 |
129 | MP0000343_altered_response_to | 0.56881903 |
130 | MP0005023_abnormal_wound_healing | 0.56405079 |
131 | MP0009115_abnormal_fat_cell | 0.56282130 |
132 | MP0002998_abnormal_bone_remodeling | 0.54802642 |
133 | MP0008873_increased_physiological_sensi | 0.54211403 |
134 | MP0002168_other_aberrant_phenotype | 0.53703670 |
135 | MP0003183_abnormal_peptide_metabolism | 0.53681309 |
136 | MP0005084_abnormal_gallbladder_morpholo | 0.50689856 |
137 | MP0001819_abnormal_immune_cell | 0.48982705 |
138 | MP0002060_abnormal_skin_morphology | 0.48950370 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.16002041 |
2 | Deep venous thrombosis (HP:0002625) | 5.75485376 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.62875480 |
4 | Xanthomatosis (HP:0000991) | 5.55391207 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.41605880 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 5.32467248 |
7 | Complement deficiency (HP:0004431) | 5.02450927 |
8 | Hyperlipoproteinemia (HP:0010980) | 4.85925984 |
9 | Hypobetalipoproteinemia (HP:0003563) | 4.77015372 |
10 | Prolonged bleeding time (HP:0003010) | 4.43119752 |
11 | Joint hemorrhage (HP:0005261) | 4.37167361 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 3.94917452 |
13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.90461551 |
14 | Hypolipoproteinemia (HP:0010981) | 3.85561837 |
15 | Epidermoid cyst (HP:0200040) | 3.84173918 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77618660 |
17 | Abnormality of complement system (HP:0005339) | 3.76431038 |
18 | Hyperammonemia (HP:0001987) | 3.73809213 |
19 | Systemic lupus erythematosus (HP:0002725) | 3.72722961 |
20 | Myositis (HP:0100614) | 3.69903571 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.67410933 |
22 | Hyperglycinemia (HP:0002154) | 3.67248581 |
23 | Hypoalphalipoproteinemia (HP:0003233) | 3.64817723 |
24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56402286 |
25 | Recurrent abscess formation (HP:0002722) | 3.52245264 |
26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.50939692 |
27 | Fat malabsorption (HP:0002630) | 3.47390977 |
28 | Hypercholesterolemia (HP:0003124) | 3.41330282 |
29 | Ketosis (HP:0001946) | 3.38981679 |
30 | Abnormality of methionine metabolism (HP:0010901) | 3.37814136 |
31 | Myocardial infarction (HP:0001658) | 3.37008479 |
32 | Abnormality of macrophages (HP:0004311) | 3.36971442 |
33 | Stomatitis (HP:0010280) | 3.34134876 |
34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.33598228 |
35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32765350 |
36 | Pustule (HP:0200039) | 3.27367037 |
37 | Hyperglycinuria (HP:0003108) | 3.22908100 |
38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.20913908 |
39 | Abnormality of glycine metabolism (HP:0010895) | 3.20913908 |
40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.20749392 |
41 | T lymphocytopenia (HP:0005403) | 3.16990626 |
42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16290060 |
43 | Hypoglycemic coma (HP:0001325) | 3.14727991 |
44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.13562423 |
45 | Recurrent fungal infections (HP:0002841) | 3.11805317 |
46 | Abnormality of T cell number (HP:0011839) | 3.04123367 |
47 | Autoimmune hemolytic anemia (HP:0001890) | 3.03475394 |
48 | Orchitis (HP:0100796) | 3.02909073 |
49 | Increased IgE level (HP:0003212) | 3.02333779 |
50 | Spontaneous abortion (HP:0005268) | 2.98621267 |
51 | Spontaneous hematomas (HP:0007420) | 2.92806506 |
52 | Retrobulbar optic neuritis (HP:0100654) | 2.87449177 |
53 | Optic neuritis (HP:0100653) | 2.87449177 |
54 | Glomerulonephritis (HP:0000099) | 2.87145512 |
55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.85919676 |
56 | Gastrointestinal infarctions (HP:0005244) | 2.85422369 |
57 | Petechiae (HP:0000967) | 2.80292617 |
58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.78314166 |
59 | Dysostosis multiplex (HP:0000943) | 2.77307048 |
60 | Mitral stenosis (HP:0001718) | 2.77139028 |
61 | Gingival bleeding (HP:0000225) | 2.74587337 |
62 | Abnormality of purine metabolism (HP:0004352) | 2.74511411 |
63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69901722 |
64 | Obstructive lung disease (HP:0006536) | 2.69901722 |
65 | Keratoconjunctivitis sicca (HP:0001097) | 2.67947259 |
66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.67098002 |
67 | Hyperbilirubinemia (HP:0002904) | 2.65613076 |
68 | Recurrent skin infections (HP:0001581) | 2.64847698 |
69 | Steatorrhea (HP:0002570) | 2.64236708 |
70 | Vasculitis (HP:0002633) | 2.62604583 |
71 | Abnormality of serum amino acid levels (HP:0003112) | 2.60083503 |
72 | Mediastinal lymphadenopathy (HP:0100721) | 2.55280227 |
73 | Skin nodule (HP:0200036) | 2.53197955 |
74 | Vascular calcification (HP:0004934) | 2.52554785 |
75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51534112 |
76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51534112 |
77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51534112 |
78 | Meningitis (HP:0001287) | 2.51164028 |
79 | Abnormality of T cells (HP:0002843) | 2.49404056 |
80 | Recurrent viral infections (HP:0004429) | 2.48469243 |
81 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45939264 |
82 | Arterial thrombosis (HP:0004420) | 2.44743916 |
83 | Gingivitis (HP:0000230) | 2.44109901 |
84 | Dicarboxylic aciduria (HP:0003215) | 2.41543235 |
85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41543235 |
86 | Axonal loss (HP:0003447) | 2.40910602 |
87 | Abnormal platelet volume (HP:0011876) | 2.40674397 |
88 | Pulmonary infiltrates (HP:0002113) | 2.39904217 |
89 | Gout (HP:0001997) | 2.38651379 |
90 | Chronic diarrhea (HP:0002028) | 2.38402277 |
91 | Cardiovascular calcification (HP:0011915) | 2.37780871 |
92 | Papilledema (HP:0001085) | 2.37050220 |
93 | Keratoconjunctivitis (HP:0001096) | 2.34644532 |
94 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33164420 |
95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33164420 |
96 | Abnormal platelet function (HP:0011869) | 2.32209738 |
97 | Impaired platelet aggregation (HP:0003540) | 2.32209738 |
98 | Abnormality of proline metabolism (HP:0010907) | 2.31723434 |
99 | Hydroxyprolinuria (HP:0003080) | 2.31723434 |
100 | Recurrent bronchitis (HP:0002837) | 2.30908338 |
101 | Ketoacidosis (HP:0001993) | 2.29784467 |
102 | Inflammation of the large intestine (HP:0002037) | 2.26473954 |
103 | Hepatocellular carcinoma (HP:0001402) | 2.24274058 |
104 | Leukocytosis (HP:0001974) | 2.24030360 |
105 | Autoimmune thrombocytopenia (HP:0001973) | 2.22792113 |
106 | Metabolic acidosis (HP:0001942) | 2.22192020 |
107 | Amyloidosis (HP:0011034) | 2.20284397 |
108 | Increased mean platelet volume (HP:0011877) | 2.19531634 |
109 | Abnormality of iron homeostasis (HP:0011031) | 2.19113297 |
110 | Sensorimotor neuropathy (HP:0007141) | 2.18753917 |
111 | Granulocytopenia (HP:0001913) | 2.17896637 |
112 | Abnormality of T cell physiology (HP:0011840) | 2.17730129 |
113 | Nephritis (HP:0000123) | 2.16858917 |
114 | Acanthocytosis (HP:0001927) | 2.15734810 |
115 | Menorrhagia (HP:0000132) | 2.15390308 |
116 | Chest pain (HP:0100749) | 2.14483268 |
117 | Vacuolated lymphocytes (HP:0001922) | 2.13514211 |
118 | Lethargy (HP:0001254) | 2.13242148 |
119 | Gangrene (HP:0100758) | 2.11160084 |
120 | Mucopolysacchariduria (HP:0008155) | 2.10383396 |
121 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10383396 |
122 | Gastrointestinal inflammation (HP:0004386) | 2.09979597 |
123 | Pancreatitis (HP:0001733) | 2.09736840 |
124 | Abnormal gallbladder morphology (HP:0012437) | 2.08645328 |
125 | Hemoptysis (HP:0002105) | 2.08324543 |
126 | Irritability (HP:0000737) | 2.07990688 |
127 | Hemorrhage of the eye (HP:0011885) | 2.07866141 |
128 | Generalized aminoaciduria (HP:0002909) | 2.07262250 |
129 | Nausea (HP:0002018) | 2.06728785 |
130 | Esophageal varix (HP:0002040) | 2.06565607 |
131 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06140342 |
132 | Thrombophlebitis (HP:0004418) | 2.05823632 |
133 | Panhypogammaglobulinemia (HP:0003139) | 2.05513294 |
134 | Eczematoid dermatitis (HP:0000976) | 2.05491863 |
135 | Interstitial pulmonary disease (HP:0006530) | 2.03339982 |
136 | Colitis (HP:0002583) | 2.03017988 |
137 | Opisthotonus (HP:0002179) | 2.02337270 |
138 | Cholelithiasis (HP:0001081) | 2.01387848 |
139 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00413606 |
140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00413606 |
141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00413606 |
142 | Delayed CNS myelination (HP:0002188) | 1.99581707 |
143 | Recurrent sinusitis (HP:0011108) | 1.99560114 |
144 | Encephalitis (HP:0002383) | 1.99530401 |
145 | Abnormality of the prostate (HP:0008775) | 1.99460162 |
146 | Tetraparesis (HP:0002273) | 1.99162772 |
147 | Recurrent bacterial skin infections (HP:0005406) | 1.98184388 |
148 | Purpura (HP:0000979) | 1.94714223 |
149 | Eosinophilia (HP:0001880) | 1.94333973 |
150 | Abnormality of B cell number (HP:0010975) | 1.92150855 |
151 | Joint swelling (HP:0001386) | 1.91989925 |
152 | Agammaglobulinemia (HP:0004432) | 1.91797399 |
153 | Hypergammaglobulinemia (HP:0010702) | 1.89921482 |
154 | Neonatal onset (HP:0003623) | 1.89663121 |
155 | Malnutrition (HP:0004395) | 1.89638885 |
156 | Proximal tubulopathy (HP:0000114) | 1.88661378 |
157 | Episodic fever (HP:0001954) | 1.88373142 |
158 | Hyperglycemia (HP:0003074) | 1.86549009 |
159 | Increased serum ferritin (HP:0003281) | 1.85945379 |
160 | Hypoglycemic seizures (HP:0002173) | 1.85808062 |
161 | Increased IgM level (HP:0003496) | 1.85507180 |
162 | Upper motor neuron abnormality (HP:0002127) | 1.84708825 |
163 | Epistaxis (HP:0000421) | 1.84475659 |
164 | Cellulitis (HP:0100658) | 1.84015716 |
165 | Urticaria (HP:0001025) | 1.83805687 |
166 | Spastic diplegia (HP:0001264) | 1.83431586 |
167 | Osteomyelitis (HP:0002754) | 1.83422787 |
168 | Elevated hepatic transaminases (HP:0002910) | 1.77341525 |
169 | Polycythemia (HP:0001901) | 1.76891175 |
170 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75924804 |
171 | Alopecia of scalp (HP:0002293) | 1.75537543 |
172 | Abnormal gallbladder physiology (HP:0012438) | 1.74585029 |
173 | Cholecystitis (HP:0001082) | 1.74585029 |
174 | Pulmonary embolism (HP:0002204) | 1.74461499 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.58549583 |
2 | FGFR4 | 3.76834148 |
3 | BCKDK | 3.35735875 |
4 | TYK2 | 3.02131460 |
5 | TAOK3 | 3.01069995 |
6 | TBK1 | 2.48452783 |
7 | NEK9 | 2.41439884 |
8 | SIK1 | 2.40888033 |
9 | MAP3K14 | 2.26560406 |
10 | MST1R | 2.16112483 |
11 | IRAK3 | 2.14198844 |
12 | JAK1 | 2.11771614 |
13 | EPHB1 | 2.06767865 |
14 | EPHA3 | 1.99447900 |
15 | TGFBR2 | 1.94905128 |
16 | KIT | 1.86589316 |
17 | PDK2 | 1.85085250 |
18 | FRK | 1.76268794 |
19 | PIK3CG | 1.74539526 |
20 | FES | 1.74490761 |
21 | GRK6 | 1.68368522 |
22 | IKBKE | 1.66623017 |
23 | PRPF4B | 1.61598804 |
24 | BMPR2 | 1.59319745 |
25 | PDK4 | 1.56128065 |
26 | PDK3 | 1.56128065 |
27 | FLT3 | 1.50730488 |
28 | JAK3 | 1.45472618 |
29 | MAP4K1 | 1.44568063 |
30 | PIM2 | 1.42486470 |
31 | ERBB4 | 1.38486278 |
32 | INSRR | 1.31537658 |
33 | SIK3 | 1.27179055 |
34 | JAK2 | 1.25876451 |
35 | IRAK4 | 1.23871291 |
36 | IRAK1 | 1.23587334 |
37 | FGFR3 | 1.19131693 |
38 | HIPK2 | 1.18567704 |
39 | ZAP70 | 1.17753988 |
40 | MAP2K3 | 1.14209662 |
41 | MAPK11 | 1.13684676 |
42 | MAPKAPK3 | 1.12807871 |
43 | BLK | 1.10720802 |
44 | TNK2 | 1.10116075 |
45 | PTK6 | 1.09736716 |
46 | KDR | 1.08595844 |
47 | ABL2 | 1.05222599 |
48 | MAPK15 | 1.05169511 |
49 | CSK | 0.97840121 |
50 | IKBKB | 0.94807060 |
51 | CSF1R | 0.94714393 |
52 | MAP3K6 | 0.92117950 |
53 | MAP3K7 | 0.89233744 |
54 | STK38 | 0.87328716 |
55 | MAP3K3 | 0.87239582 |
56 | CAMK1D | 0.87219457 |
57 | MST4 | 0.86754874 |
58 | MAP3K13 | 0.83716712 |
59 | PRKAA2 | 0.82549135 |
60 | PIK3CA | 0.81097850 |
61 | PINK1 | 0.80903782 |
62 | TXK | 0.79543782 |
63 | SCYL2 | 0.79360512 |
64 | KSR2 | 0.79008885 |
65 | MATK | 0.78220773 |
66 | MAP3K12 | 0.76654713 |
67 | MAPK7 | 0.73028325 |
68 | TRIB3 | 0.72806281 |
69 | TIE1 | 0.70026504 |
70 | MAPK4 | 0.69550846 |
71 | ARAF | 0.68934275 |
72 | GRK7 | 0.67595657 |
73 | RET | 0.67559801 |
74 | RIPK4 | 0.66634118 |
75 | BTK | 0.66402428 |
76 | MARK2 | 0.66260952 |
77 | MAP2K1 | 0.65918105 |
78 | PDGFRB | 0.65572038 |
79 | MAP4K2 | 0.65358105 |
80 | CHUK | 0.63391709 |
81 | SYK | 0.63154076 |
82 | SGK3 | 0.62815926 |
83 | CAMKK2 | 0.62205335 |
84 | CDC42BPA | 0.61592965 |
85 | CAMKK1 | 0.61459092 |
86 | CDK12 | 0.60902014 |
87 | MAP2K4 | 0.60544258 |
88 | STK3 | 0.60048123 |
89 | MAP2K6 | 0.59484786 |
90 | TESK2 | 0.59244921 |
91 | NUAK1 | 0.58411972 |
92 | PTK2B | 0.57438502 |
93 | ITK | 0.57091849 |
94 | YES1 | 0.57085032 |
95 | WNK1 | 0.56996439 |
96 | GSK3A | 0.56569677 |
97 | DYRK1B | 0.56382348 |
98 | IGF1R | 0.56117363 |
99 | PRKCQ | 0.55919873 |
100 | MYLK | 0.55834361 |
101 | MAP3K1 | 0.55758537 |
102 | PDPK1 | 0.55679710 |
103 | NEK6 | 0.54240976 |
104 | TRPM7 | 0.54119673 |
105 | IRAK2 | 0.54064777 |
106 | MAP3K2 | 0.53282622 |
107 | SIK2 | 0.52996330 |
108 | FGR | 0.52064038 |
109 | MAPK12 | 0.51968474 |
110 | LYN | 0.51575023 |
111 | TEC | 0.51527335 |
112 | HCK | 0.51235309 |
113 | AKT3 | 0.50533433 |
114 | LCK | 0.49464060 |
115 | PDK1 | 0.48595242 |
116 | FYN | 0.48354519 |
117 | GRK5 | 0.46615393 |
118 | PKN2 | 0.46317429 |
119 | MARK3 | 0.44083009 |
120 | LATS1 | 0.44069676 |
121 | MAP2K2 | 0.43963190 |
122 | CAMK2G | 0.42987091 |
123 | PRKACG | 0.42379001 |
124 | PRKD2 | 0.42218921 |
125 | MET | 0.41369661 |
126 | PRKAA1 | 0.41070444 |
127 | MAP3K5 | 0.40635043 |
128 | PRKCD | 0.40418555 |
129 | SGK2 | 0.39484753 |
130 | PRKG2 | 0.39016253 |
131 | ABL1 | 0.38908526 |
132 | STK10 | 0.38510263 |
133 | NLK | 0.38024752 |
134 | PIM1 | 0.36581021 |
135 | RIPK1 | 0.36239475 |
136 | ERBB2 | 0.36150679 |
137 | TTN | 0.35774369 |
138 | CDK6 | 0.35763538 |
139 | FER | 0.35707587 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.19563555 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.07195296 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.03359903 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.89088991 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88189106 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78563816 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50264956 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47869583 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38769606 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38322093 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35483085 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26106924 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.18843843 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17136732 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16083551 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.07122481 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95078889 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91620736 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90548095 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.90520370 |
21 | Allograft rejection_Homo sapiens_hsa05330 | 1.84275517 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82136709 |
23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80734028 |
24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79916293 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79484443 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78281715 |
27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77033607 |
28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73475019 |
29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73404467 |
30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72907965 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.71488639 |
32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70920985 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69550345 |
34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.68591744 |
35 | Platelet activation_Homo sapiens_hsa04611 | 1.60918534 |
36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.60240304 |
37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53200874 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53005725 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.52073870 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51335840 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47396381 |
42 | Asthma_Homo sapiens_hsa05310 | 1.46729206 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43840529 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39785390 |
45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36748663 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.34473238 |
47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33744207 |
48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31943178 |
49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31884384 |
50 | Bile secretion_Homo sapiens_hsa04976 | 1.31766746 |
51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29502001 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29426719 |
53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28118768 |
54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27535730 |
55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27419678 |
56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24827200 |
57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24266200 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.23291813 |
59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20063704 |
60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19878045 |
61 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14561288 |
62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13720846 |
63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09752933 |
64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08546030 |
65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08433412 |
66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07726206 |
67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07141076 |
68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04488578 |
69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01424201 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01162544 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00689195 |
72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99037270 |
73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98620716 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92143621 |
75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89135151 |
76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87471087 |
77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87056573 |
78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85921907 |
79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85799638 |
80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85106489 |
81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84383715 |
82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84125038 |
83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83029160 |
84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82297459 |
85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82034812 |
86 | Hepatitis B_Homo sapiens_hsa05161 | 0.81791774 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81082180 |
88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80177185 |
89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80125205 |
90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79465702 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74502875 |
92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73013555 |
93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72492970 |
94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69856756 |
95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69555790 |
96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68084127 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67597274 |
98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66569216 |
99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65341058 |
100 | Amoebiasis_Homo sapiens_hsa05146 | 0.64757780 |
101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64152446 |
102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63814662 |
103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63617905 |
104 | Salmonella infection_Homo sapiens_hsa05132 | 0.62593472 |
105 | Lysosome_Homo sapiens_hsa04142 | 0.61979456 |
106 | Renin secretion_Homo sapiens_hsa04924 | 0.59817056 |
107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59743613 |
108 | Apoptosis_Homo sapiens_hsa04210 | 0.58230332 |
109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57643667 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.56868512 |
111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55697818 |
112 | Lysine degradation_Homo sapiens_hsa00310 | 0.53249624 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52685435 |
114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51344305 |
115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51262137 |
116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50636445 |
117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50124860 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49413479 |
119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48737401 |
120 | Prion diseases_Homo sapiens_hsa05020 | 0.48709068 |
121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48434742 |
122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47159804 |
123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45755946 |
124 | Shigellosis_Homo sapiens_hsa05131 | 0.45166330 |
125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45058029 |
126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44133711 |
127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41697448 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40408258 |
129 | Malaria_Homo sapiens_hsa05144 | 0.38939927 |
130 | Pertussis_Homo sapiens_hsa05133 | 0.38317534 |
131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38304461 |
132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37666869 |
133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35215477 |
134 | Insulin resistance_Homo sapiens_hsa04931 | 0.33816900 |
135 | Legionellosis_Homo sapiens_hsa05134 | 0.33142262 |
136 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32158218 |
137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30804625 |
138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27407729 |
139 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.23088876 |
140 | Hepatitis C_Homo sapiens_hsa05160 | 0.19261591 |
141 | Other glycan degradation_Homo sapiens_hsa00511 | 0.19116684 |
142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18565074 |
143 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.18078463 |
144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17383687 |
145 | Phagosome_Homo sapiens_hsa04145 | 0.17370832 |
146 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.16262241 |
147 | Tuberculosis_Homo sapiens_hsa05152 | 0.16130721 |
148 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.15449773 |
149 | Measles_Homo sapiens_hsa05162 | 0.14171812 |
150 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.13797806 |
151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13618901 |
152 | Influenza A_Homo sapiens_hsa05164 | 0.11941427 |
153 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.10274995 |
154 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.09941912 |